Neural-epithelial cell interplay:: In vitro evidence that vagal mediators increase PGE2 production by human nasal epithelial cells

被引:8
作者
Jallat-Daloz, I [1 ]
Cognard, JL [1 ]
Badet, JM [1 ]
Regnard, J [1 ]
机构
[1] Fac Med, Physiol Lab, F-25030 Besancon, France
关键词
D O I
10.2500/108854101778249267
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
During inflammatory states, airway epithelial cells are stimulated by various proinflammatory mediators to synthesize paracrine mediators including prostaglandin E-2, which likely contributes to the recurrence of allergic inflammation. We studied the effects of acetylcholine (ACh) and substance P (SP) on PGE(2) release because these two neuromediators are widely involved in airway inflammation, e.g., to trigger mucosal vasodilation and plasma exudation. PGE, release was studied at baseline and after addition of ACh and SP (10(-10) to 10(-7) M) in primary cultures of human nasal epithelial cells from control mucosa, inflammatory non-atopic mucosa and inflammatory atopic mucosa. The mediators' effects on COX 2 mRNA were assessed by Nor-them blotting. We also tested the effect of atropine and SR140333, inhibitors of ACh and SP, respectively. The spontaneous release of PGE(2) was about three times higher in cells from atopic subjects. ACh and SP markedly increased PGE(2) release (by more than 1.5 times) and this effect tvas similar whether the sampled tissues were inflammatory or not. In cells from atopic subjects this neuromediator effect led to a fivefold increase in PGE(2) release, as compared to baseline production by cells from control mucosa. This stimulation of PGE(2) release by neural mediators was inhibited by specific antagonists. ACh and SP increased COX 2 mRNA in the three groups. Thus, neuromediators can bolster PGE(2) production in the airway, likely reinforcing inflammation. In conclusion, these data provide evidence that the interplay of nerve fibers and airway epithelial cells is likely important in inflammatory conditions as, e.g., allergy and asthma.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 24 条
[1]   CYTOKINES AS MEDIATORS OF CHRONIC ASTHMA [J].
BARNES, PJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :S42-S49
[2]   Bronchial epithelial cells in asthma [J].
Campbell, AM .
ALLERGY, 1997, 52 (05) :483-489
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]   SENSITIVITY OF THE HUMAN COUGH REFLEX - EFFECT OF INFLAMMATORY MEDIATORS PROSTAGLANDIN-E2, BRADYKININ, AND HISTAMINE [J].
CHOUDRY, NB ;
FULLER, RW ;
PRIDE, NB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (01) :137-141
[5]   CYCLOOXYGENASE METABOLISM OF ENDOGENOUS ARACHIDONIC-ACID BY CULTURED HUMAN TRACHEAL EPITHELIAL-CELLS [J].
CHURCHILL, L ;
CHILTON, FH ;
RESAU, JH ;
BASCOM, R ;
HUBBARD, WC ;
PROUD, D .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (02) :449-459
[6]   AFFERENT VAGAL-C FIBER INNERVATION OF THE LUNGS AND AIRWAYS AND ITS FUNCTIONAL-SIGNIFICANCE [J].
COLERIDGE, JCG ;
COLERIDGE, HM .
REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY, 1984, 99 :1-110
[7]   IN-VITRO AND IN-VIVO BIOLOGICAL-ACTIVITIES OF SR140333, A NOVEL POTENT NONPEPTIDE TACHYKININ NK1, RECEPTOR ANTAGONIST [J].
EMONDSALT, X ;
DOUTREMEPUICH, JD ;
HEAULME, M ;
NELIAT, G ;
SANTUCCI, V ;
STEINBERG, R ;
VILAIN, P ;
BICHON, D ;
DUCOUX, JP ;
PROIETTO, V ;
VANBROECK, D ;
SOUBRIE, P ;
LEFUR, G ;
BRELIERE, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (03) :403-413
[8]   Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation [J].
Gauvreau, GM ;
Watson, RM ;
O'Byrne, PM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :31-36
[9]  
JORDANA M, 1995, ASTHMA RHINITIS, P156
[10]   Acetylcholine and nicotine stimulate the release of granulocyte-macrophage colony stimulating factor from cultured human bronchial epithelial cells [J].
Klapproth, H ;
Racké, K ;
Wessler, I .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) :472-475